These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 312087)

  • 21. So you suspect mixed connective tissue disease (MCTD). Which tests to perform?
    Gladman DD; Urowitz MB
    Int J Dermatol; 1984; 23(6):392-3. PubMed ID: 6384083
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mixed connective tissue disease (Sharp). Nosologic entity or a subgroup of systemic lupus erythematosus?].
    Sönnichsen N; Ziegler H; Barthelmes H; Albrecht-Nebe H; Schulze P; Brenke A
    Dermatol Monatsschr; 1988; 174(3):137-41. PubMed ID: 3260197
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased serum levels of immunoglobulins, C-reactive protein, type 1 and type 2 cytokines in patients with mixed connective tissue disease.
    Bakri Hassan A; Rönnelid J; Gunnarsson I; Karlsson G; Berg L; Lundberg I
    J Autoimmun; 1998 Oct; 11(5):503-8. PubMed ID: 9802936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of the characterization of anti-ribonucleoproteins and anti-Sm antibodies by immunoblotting and immunoprecipitation in connectivitis].
    Combe B; Lussiez V; Rucheton M; Graafland H; Brunel C; Sany J
    Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):47-9. PubMed ID: 3281242
    [No Abstract]   [Full Text] [Related]  

  • 26. Detection of antinuclear ribonucleoprotein (nRNP) antibody producing cells in peripheral blood lymphocytes from patients with mixed connective tissue disease.
    Nakano K; Tanimoto K; Möroi Y; Miyamoto T
    J Rheumatol; 1985 Oct; 12(5):924-7. PubMed ID: 3910834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antinuclear antibodies in the investigation of rheumatic diseases.
    Fritzler MJ
    Bull Rheum Dis; 1985; 35(6):1-10. PubMed ID: 3879803
    [No Abstract]   [Full Text] [Related]  

  • 28. [Occurrence of autoantibodies and the clinical course of mixed connective tissue disease, systemic scleroderma, dermatomyositis, polymyositis and Sjögren's syndrome].
    Prokop J; Zietkiewicz E; Słomski R
    Przegl Dermatol; 1986; 73(4):327-31. PubMed ID: 3333867
    [No Abstract]   [Full Text] [Related]  

  • 29. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
    Watanabe S; Miyawaki S
    Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
    [No Abstract]   [Full Text] [Related]  

  • 30. IgG subclass distribution of autoantibodies to DNA and to nuclear ribonucleoproteins in autoimmune diseases.
    Zouali M; Jefferis R; Eyquem A
    Immunology; 1984 Mar; 51(3):595-600. PubMed ID: 6230310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
    Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
    J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
    Benhamou CL; Amor B; Menkes CJ; Delbarre F
    Ann Med Interne (Paris); 1982; 133(2):72-9. PubMed ID: 6979281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
    Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
    Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sharp's syndrome].
    Kahn MF
    Rev Prat; 1990 Sep; 40(21):1944-5. PubMed ID: 2237187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mixed connective tissue disease].
    Walravens M
    Acta Rhumatol Belg; 1978; 2(3-4):109-23. PubMed ID: 316262
    [No Abstract]   [Full Text] [Related]  

  • 37. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinical significance of the in vivo antinuclear antibody phenomenon.
    Williams WV; Barjenbrach P; Adelstein E; Sharp GC; Walker SE
    Arch Pathol Lab Med; 1986 Sep; 110(9):798-802. PubMed ID: 3530186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed connective tissue disease in children.
    Peskett SA; Ansell BM; Fizzman P; Howard A
    Rheumatol Rehabil; 1978 Nov; 17(4):245-8. PubMed ID: 310575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
    Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
    J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.